FoxBio
Lafayette
About FoxBio
FoxBio is a developer of a small molecules techniques intended to reduce senescent cells in human bodies. The company's techniques targets the pro-survival pathways of senescent cells to remove them from the body, enabling patients to have multiple health benefits and delay the onset of age related diseases.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Total funding: $10.0M
- Last round: Series Unknown (Jul 2018)
Industries & Categories
Biopharma, Biotechnology, Life Science
Canonical: https://fsome.com/organization/foxbio-154212 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.